FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092265 [Registered on: 04/08/2025] Trial Registered Prospectively
Last Modified On: 01/08/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare the visual outcomes of two refractive surgery procedures Small Incision Lenticule Extraction and ICL in patients of moderate refractive error 
Scientific Title of Study   To compare visual outcomes and patient satisfaction levels in patients undergoing implantable Collamer lens ICL implantation versus Small Incision Lenticule Extraction in cases of moderate myopia and myopic astigmatism 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
aloksati_123@rediffmail.com  ClinicalTrials.gov 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Supriya Dhar  
Designation  Assoc Prof 
Affiliation  Army Hospital RR Delhi Cantt 
Address  Dept Of Ophthalmology Army Hospital RR Delhi Cantt

South West
DELHI
110010
India 
Phone  8974795579  
Fax    
Email  supreme4995@live.com  
 
Details of Contact Person
Scientific Query
 
Name  Supriya Dhar  
Designation  Assoc Prof 
Affiliation  Army Hospital RR Delhi Cantt 
Address  Dept Of Ophthalmology Army Hospital RR Delhi Cantt


DELHI
110010
India 
Phone  8974795579  
Fax    
Email  supreme4995@live.com  
 
Details of Contact Person
Public Query
 
Name  Supriya Dhar  
Designation  Assoc Prof 
Affiliation  Army Hospital RR Delhi Cantt 
Address  Dept Of Ophthalmology Army Hospital RR Delhi Cantt


DELHI
110010
India 
Phone  8974795579  
Fax    
Email  supreme4995@live.com  
 
Source of Monetary or Material Support  
Dept Of Ophthalmology Army Hospital RR Delhi Cantt New Delhi-110010 
NIL 
 
Primary Sponsor  
Name  Dr Supriya Dhar 
Address  Dept Of Ophthalmology Army Hospital RR Delhi Cantt-10 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Supriya Dhar  Army Hospital RR Delhi Cantt  Dept Of Ophthalmology Army Hospital RR Delhi Cantt
South West
DELHI 
8974795579

supreme4995@live.com 
Supriya Dhar  New Delhi  Army Hospital RR Delhi Cantt
South West
DELHI 
8974795579

supreme4995@live.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Army Hospital)R&R), Delhi Cantt  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  NIL 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Implantable Collamer Lens implantation  Implantable Collamer lens implantation will be carried out in the comparison arm of 50 eyes of 25 patients. The findings of vision and other related features between the intervention group and the comparator group will be compared along with assessing quality of life after surgery in a questionnaire form till 21 months after surgery  
Intervention  Small Incision Lenticule Extraction SMILE  In 50 eyes of 25 Randomly allocated patients Small Incision Lenticule Extraction surgery will be carried out 
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  Spherical equivalent of negative 3 to negative 6 Dioptres

Refractive cylinder less than or equal to 2 Dioptres

Best spectacle-corrected visual acuity of 20 by 40 or better

A spherical or cylindrical error that has progressed at negative half Dioptres or less per year before the baseline measurement.

The contact lens must have been removed at least two weeks before the baseline measurement.

No evidence of irregular astigmatism on corneal topography

Anterior chamber depth more than or equal to two point eight millimetre

Corneal endothelial cell count more than or equal to two thousand cells per square millimetre
 
 
ExclusionCriteria 
Details  Progressive or unstable myopia and astigmatism

Clinical or corneal topographic evidence of keratoconus

Residual recurrent or active ocular disease and retinal disease

Previous corneal surgery

Thinnest Pachymetry les than or equal to four hundred ninety micrometre

Residual Stromal Bed less than or equal to two hundred and eighty micrometre in patients undergoing Small Incision Lenticule extraction

Taking systemic medications and systemically immunocompromised or systemic diseases likely to affect wound healing such as diabetes connective tissue disease and severe atopy pregnant or nursing females.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1) Objectively measure pre- and post-operative higher-order ocular aberrations, including spherical aberration, vertical coma, trefoil, tetrafoil, and contrast sensitivity and subjectively use a quality of vision questionnaire to assess the same.  Day 01
01 week
01 month
03 months
06 months
12 months
18 months and 21 months 
 
Secondary Outcome  
Outcome  TimePoints 
Assessment of Uncorrected and corrected visual acuity, efficacy and safety of the procedure, and endothelial cell count between two groups.
 
Day 01
01 week
01 months
03 months
06 months
12 months
18 months
21 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   12/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Over the past 20 years, refractive surgery has witnessed significant advancements, including Small Incision Lenticule Extraction (SMILE) and Implantable Collamer Lens (ICL). SMILE’s flapless design reduces postoperative dryness and offers biomechanical stability, making it a safe and effective option for patients with adequate corneal thickness and no irregularities. On the other hand, ICL is a minimally invasive procedure that implants a Collamer lens in phakic eyes, correcting a more comprehensive range of myopic correction (0 to -18.00 D) with a short recovery time. 

            While ICL is the preferred surgery for high myopia, there are limited studies on its use in correcting mild and moderate myopia. Comparing EVO-ICL and laser-assisted in situ keratomileusis (LASIK), ICL was found to be safer, more predictable, and more stable, with better contrast sensitivity and lower higher-order aberrations (HOAs). The current literature primarily compares the visual outcomes of ICL and SMILE in patients with high myopia.

The most extensive study conducted in this group was by Aruma et al where 32 eyes of 20 patients underwent EVO-ICL implantation, and 35 eyes of 19 patients underwent SMILE. Changes in coma after ICL were significantly less than after SMILE. The leading complaints after ICL and SMILE were halos (84.4%) and blurred vision (65.7%). A study by Ganesh et al in Indian eyes compared three procedures: Toric-ICL. Femtosecond LASIK and SMILE in 30 patients with low to moderate myopia over a one-year follow-up period concluded that the Quality of vision and patient satisfaction with Toric ICL and SMILE were similar and better than Femtosecond LASIK.

            There are very few long-term studies, especially Indian studies, that compare the effects on vision quality objectively and subjectively after both procedures in cases of moderate myopia and myopic astigmatism; hence, the need to carry out this study. A more extensive population-based comparative analysis would be needed to compare the visual performance between the two procedures.

 
Close